CEBPA and acute myeloid leukemia: As CSF3R mutations appear to correlate most strongly with the presence of C-terminal CEBPA mutations in human AML, and our colony assay data presented in Fig. 1 demonstrate more potent oncogenic activity in vitro we investigated whether similar biology occurs in in vivo.